Home » Topics » Regulatory » Patents

Patents
RSS

The Center Translational Drug Development patents novel Rho kinase inhibitors

Dec. 5, 2016

Kainos Medicine presents Brd4 inhibitors

Dec. 2, 2016

Medshine Discovery develops PDE2A inhibitors and TNF-alpha production inhibitors

Dec. 2, 2016

GlaxoSmithKline describes RIP-1 kinase 1 inhibitors

Dec. 2, 2016

Wistar Institute discloses EBNA-1 inhibitors

Dec. 2, 2016

Kalyra Pharmaceuticals patents EGFR inhibitors

Dec. 2, 2016

Boehringer Ingelheim prepares and tests IGF-1R inhibitors

Dec. 1, 2016

Roche patent describes TLR7 agonists for HBV infections

Dec. 1, 2016

Selvita reports PFKFB inhibitors in patent

Dec. 1, 2016

Australian institutes describe IRAP inhibitors

Dec. 1, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...